Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.57B |
| 2 |
Microsoft
MSFT
|
+$1.4B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Amazon
AMZN
|
+$1.19B |
| 5 |
Broadcom
AVGO
|
+$1.13B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WRK
WestRock Company
WRK
|
+$316M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$187M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$159M |
| 4 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$139M |
| 5 |
Cadence Design Systems
CDNS
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.03% |
| 2 | Financials | 12.84% |
| 3 | Healthcare | 11.54% |
| 4 | Consumer Discretionary | 10.45% |
| 5 | Industrials | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3351
Baytex Energy
BTE
$2.92B
| $1.01M | ﹤0.01% |
337,705
-429,645
| -56% | -$1.46M |
|
3352
Ambev
ABEV
$46.4B
| $1.01M | ﹤0.01% |
414,123
-60,313
| -13% | -$135K |
|
3353
Expensify
EXFY
$245M
| $1.01M | ﹤0.01% |
514,948
+52,385
| +11% | +$109K |
|
|
MRNS
3354
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $1M | ﹤0.01% |
568,517
-48,878
| -8% | -$68.2K |
|
3355
Travelzoo
TZOO
$75.4M
| $991K | ﹤0.01% |
82,241
+7,857
| +11% | +$85.6K |
|
3356
Laser Photonics
LASE
$57.2M
| $989K | ﹤0.01% |
60,656
+21,106
| +53% | +$96.2K |
|
3357
M-tron Industries
MPTI
$380M
| $989K | ﹤0.01% |
23,706
+3,718
| +19% | +$129K |
|
3358
Riverview Bancorp
RVSB
$108M
| $988K | ﹤0.01% |
209,781
+5,551
| +3% | +$24.7K |
|
3359
Relmada Therapeutics
RLMD
$527M
| $987K | ﹤0.01% |
304,502
+44,004
| +17% | +$143K |
|
3360
Comp X International
CIX
$371M
| $984K | ﹤0.01% |
33,674
+265
| +0.8% | +$7.03K |
|
|
GRFS
3361
Grifois
GRFS
$5.4B
| $982K | ﹤0.01% |
110,532
+39,733
| +56% | +$323K |
|
|
IVAC
3362
DELISTED
Intevac Inc
IVAC
| $977K | ﹤0.01% |
287,163
+8,063
| +3% | +$29.4K |
|
3363
Aclaris Therapeutics
ACRS
$869M
| $974K | ﹤0.01% |
846,446
+72,309
| +9% | +$88.7K |
|
|
GOCO
3364
DELISTED
GoHealth
GOCO
| $973K | ﹤0.01% |
103,735
+3,205
| +3% | +$32.4K |
|
3365
LivePerson
LPSN
$32.3M
| $961K | ﹤0.01% |
50,040
-5,402
| -10% | -$91.6K |
|
|
ACR
3366
ACRES Commercial Realty
ACR
$108M
| $961K | ﹤0.01% |
61,346
-11,455
| -16% | -$171K |
|
|
CKPT
3367
DELISTED
Checkpoint Therapeutics
CKPT
| $958K | ﹤0.01% |
427,651
+124,787
| +41% | +$288K |
|
3368
inTEST
INTT
$177M
| $957K | ﹤0.01% |
131,106
+8,161
| +7% | +$67.7K |
|
|
NNE
3369
Nano Nuclear Energy
NNE
$1.01B
| $954K | ﹤0.01% |
+66,224
| New | +$931K |
|
3370
CytomX Therapeutics
CTMX
$754M
| $948K | ﹤0.01% |
803,531
+34,032
| +4% | +$43.2K |
|
3371
NeoVolta
NEOV
$155M
| $947K | ﹤0.01% |
306,324
+15,427
| +5% | +$43.4K |
|
3372
Eledon Pharmaceuticals
ELDN
$285M
| $942K | ﹤0.01% |
378,058
+33,569
| +10% | +$89.9K |
|
3373
Citius Pharmaceuticals
CTXR
$18.7M
| $941K | ﹤0.01% |
75,158
+9,306
| +14% | +$157K |
|
3374
OPAL Fuels
OPAL
$70.7M
| $940K | ﹤0.01% |
257,549
+41,250
| +19% | +$155K |
|
3375
CSP Inc
CSPI
$82.1M
| $934K | ﹤0.01% |
71,886
-720
| -1% | -$10.1K |
|
Similar funds
Geode Capital Management's Q3 2024 Portfolio in Review
As of Q3 2024, Geode Capital Management held 4,685 positions worth $1.23T, up 8.4% from $1.14T the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Geode Capital Management's Q3 2024 filing shows 98 new, 3,266 increased, 979 reduced and 150 closed positions. Its largest new stake was Smurfit Westrock: 12,733,113 shares worth $627M. The largest sale was WestRock Company, an estimated $316M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2024 buy was Smurfit Westrock: 12,733,113 shares worth $627M.
- Geode Capital Management added most to Apple in Q3 2024, an estimated $4.57B increase.
- Geode Capital Management's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $187M.
- Geode Capital Management fully exited WestRock Company in Q3 2024, selling an estimated $316M.
- Geode Capital Management's ten largest holdings make up 30% of its $1.23T portfolio in Q3 2024.
- Geode Capital Management opened 98 new positions and closed 150 in Q3 2024.
- Geode Capital Management's portfolio value rose 8.4% quarter-over-quarter to $1.23T.
Based on Geode Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.